A highly asymmetric setup: meaningful upside if the buyer returns, limited downside if it doesn’t.
A Take-Private Spread That Doubled on No News
The spread is wide, and this could be a pretty timely setup.
Yet Another Odd-Lot Tender Offer
Easy spread, with minimal cancellation or amendment risk.
Wide Spread on a Merger That Needs Just a Few More Votes
Every other condition is done. What remains is an administrative problem with a short timeline.
Buying the Buyer, Not the Target
The parent will trade at a ridiculously low valuation once it takes its cash cow subsidiary private at a steal of a price.
Royalty Shell at 50% Discount to Asset Value
Strategic review is ongoing, messy accounting hides the actual profitability.
A Bid Is on the Table yet the Discount Is Still Wide
Comparable transactions and peer marks point to the bid landing above the current price.
Wide Spread and a Possible Bidding War
The offer was already raised once.
Spread Widened Sharply after Recent Price Drop
Same buyout, second entry point.
Potential Takeover with 40% Upside
The optionality on a sale looks close to free, in a business that has been quietly compounding.
A Wide Spread on a Deal That Looks Solid
While the offer is still non-binding, several factors suggest that the spread might be too wide.
Odd-Lot Tender Offer
Easy spread, with minimal cancellation or amendment risk.
Pending Buyout by a Controlling Shareholder
When one share class prices in a buyout and the other doesn’t.
Market Overreaction
65% potential upside on a rebound.
A Fast and Clean Liquidation
The asset sales are already signed. 30%+ IRR.
A Tender Offer With an Odd-Lot Priority
Spread is quite wide, and the window closes in two weeks.
A Wide Spread on a Merger the Major Holders Already Blessed
This is a straightforward arb with a wide spread and closing expected in three months.
A Wide Spread on a Bid From Major Holders
This significantly improved offer might be difficult to refuse.
Yet Another Straightforward Merger Arb
With closing expected in 6 months, the IRR is compelling.
A Strategic Review With Earnings Inflecting
Review Near the Finish Line, 50%+ Upside in a Sale Scenario
Straightforward Merger Arb
20% upside with closing a couple of months out.
A Cheap Bank at a 25% Discount to Book
Asset redeployment could close the gap to peers trading above book.
Cheap Optionality in a Busted Biopharma
Massive discount to net cash, reputable management, and activist in place.
Bidding War Brewing
Multiple bidders circling, a few offers are already on the table.
Cash-Rich Operating Business at No Cost
Ridiculous Privatization Attempt: 40-70% Bump Expected
A Big Haircut on the Interest Bill
Upcoming refinancing could lift FCF by 50%.
A Mandatory Offer
20% potential upside.
A Clean “Free CVR” Setup
Closing is expected this quarter.
All in the Founders’ Hands
Approval is a formality, valuation is anchored by cash, spread is pretty wide.
Governance Shift Could Lead to a Takeover
The spread is wide, and the timeline is tight.
Privatization With a Potential Price Bump
The spread is wide, and the timeline is tight.
Activist Pressure on a Net-Net
Super-voting shares eliminated, board exposed. Net cash offers 40%+ upside from here.
Sale & Large Capital Return
Capital return alone could exceed the market cap.
Tender Offer & Liquidation
40%-80% Potential Upside
Potential Buyout With 40% Upside
If there is no deal, the downside is probably limited to only 10% to 15%.
Odd-Lot Tender Offer
Easy spread, with minimal cancellation or amendment risk.
A Clean and Low-Risk Liquidation Play
The wind-down should be completed this year.
Boring Business With an Intriguing Sale Catalyst
The market has largely ignored the recent developments, which makes the opportunity quite asymmetric.
Focus List: 17 Actionable Special Sits
It has been a very productive year so far. We have published 73 new investment ideas on SSI, and while many have already played out, 42 write-ups are still marked as active.
Taking It Private to Bring It Back to Life
The founder is leading a buyout to revive the struggling business.
Share Class Arbitrage
After a successful first round in this share class arbitrage last year, it’s time for round two.
CEO Floats Lowball Offer and Invites Competing Bids
The company is now in play, and downside is protected.
Yet Another Asymmetric Bet With a Twist
Downside risk limited at 6-8%, potential upside is substantial.
Potential Takeover and/or Bidding War
30% potential upside, a few interested parties are already at the table
Odd-Lot Tender Offer With €200+ Upside
Tender expires mid-June, minimal risk involved
Asymmetric Bet with Multibagger Upside
Protected downside, a number of precedents worked out very well
Tender Offer With a Free Option
Trades below the tender price range, expiration date is set for mid-June
Potential Liquidation or a Sale
Strategic review is ongoing, potential upside could range between 30%-60%
Merger Arb Created by Market Overreaction
14%+ upside, closing expected in 1.5 months
Merger Arbitrage + Bidding War
20%+ upside, exclusive talks underway, several other interested bidders
Merger Arb with 75% Spread
Multiple interested parties, full strategic review has been launched
Strategic Review with Activists Involved
At least 40% upside conservative sum-of-the-parts valuation
Merger Arbitrage with Free CVR
Trades below cash consideration
Liquidation of Real Estate Trust
30%+ upside, full portfolio is already on the market
Opportunistic Privatization by Management
20% spread, founders & management are very motivated to close the transaction